Cell-line development enhances biopharmaceutical production capacity and quality, but complex biologics like bsAbs and ADCs present new challenges.

Inside every living cell, tiny molecular machines are constantly in motion, shifting shapes, tugging on membranes and shuttling ions from one side to the other. That restless activity does more than ...